A discovery about the mechanisms that enable the immune system to sustain long-term protection could revolutionize treatment for chronic disease and cancer.
Light Horse emerges with $62m and Novartis partnership worth up to $1bn – Pharmaceutical Technology
Light Horse pursues a function-first approach with its genetic editing-based platform. Image credit: Shutterstock/ Hyejin Kang. Light Horse Therapeutics has galloped on to the biotech
January 10, 2025